TELADOC HEALTH, INC. (TDOC) Return on equity 2016–2025
TELADOC HEALTH, INC. (TDOC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-14.5%FY2025 · since FY2016: -32.1% → -14.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -14.5% | +52.7 pp |
| FY2024 | -67.1% | -57.7 pp |
| FY2023 | -9.5% | +582.4 pp |
| FY2022 | -591.9% | -589.2 pp |
| FY2021 | -2.7% | +0.4 pp |
| FY2020 | -3.1% | +6.7 pp |
| FY2019 | -9.7% | -0.2 pp |
| FY2018 | -9.6% | +9.5 pp |
| FY2017 | -19.1% | +13.0 pp |
| FY2016 | -32.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More TDOC financial trends
TDOC RevenueTDOC Net incomeTDOC Net marginTDOC Gross profitTDOC Gross marginTDOC Operating incomeTDOC Operating marginTDOC Operating cash flowTDOC Free cash flowTDOC Capital expendituresTDOC Stock buybacksTDOC Dividends paidTDOC Total assetsTDOC Total liabilitiesTDOC Shareholders’ equityTDOC overview →